Palvella Therapeutics, Inc. · NASDAQ:PVLA

Jenkins George M sold 27,500 Palvella Therapeutics, Inc. shares (Form 4)

Traded Oct 12 to Oct 14, 2026 · Filed Oct 14, 2026

From Oct 12 to Oct 14, 2026, Jenkins George M (Director) sold 27,500 Palvella Therapeutics, Inc. shares at an average US$130.16 for US$3.58M under a trading plan, leaving 132,616 shares. Filed Oct 14, 2026 (Form 4).

Sold
27,500 shares
Price
US$130.16 average (US$121.14 to US$136.44)
Value
US$3.58M
Holding after
132,616 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 12, 2026Common StockSale5,095US$132.62155,021Direct
Oct 12, 2026Common StockSale2,458US$133.25152,563Direct
Oct 12, 2026Common StockSale3,335US$134.21149,228Direct
Oct 12, 2026Common StockSale1,447US$135.50147,781Direct
Oct 12, 2026Common StockSale817US$136.44146,964Direct
Oct 13, 2026Common StockSale2,004US$128.52144,960Direct
Oct 13, 2026Common StockSale1,644US$129.23143,316Direct
Oct 13, 2026Common StockSale990US$130.48142,326Direct
Oct 13, 2026Common StockSale1,035US$131.49141,291Direct
Oct 13, 2026Common StockSale579US$132.40140,712Direct
Oct 13, 2026Common StockSale922US$133.72139,790Direct
Oct 14, 2026Common StockSale476US$121.14139,314Direct
Oct 14, 2026Common StockSale2,072US$122.62137,242Direct
Oct 14, 2026Common StockSale2,604US$123.29134,638Direct
Oct 14, 2026Common StockSale920US$124.37133,718Direct
Oct 14, 2026Common StockSale597US$125.33133,121Direct
Oct 14, 2026Common StockSale505US$126.55132,616Direct

Source

Download original · View original at SEC

Related